Delivery Order SPE2DB22D9367-SPE2DB26FSU79
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a $19,662.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The order, with an ultimate completion date of October 20, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, competing...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was awarded on October 17, 2025. This award carries no set-aside designation, demonstrating the vendor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract involves no...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,021.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, was issued without set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,234.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of September 19, 2025, was executed without a set-aside designation. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $6,028.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The award, issued on September 19, 2025, with an ultimate completion date of October 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB26FSU79Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,113.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the award was made through competitive procurement. The delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial capability as a critical supplier within the federal pharmaceutical supply chain, with the parent IDC (SPE2DR) valued at $499,999,999 and extending through December 31, 2036. The company's extensive product portfolio spans branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with recent delivery orders ranging from minimal purchases to awards exceeding $115,000. EXPAREL, a specialty surgical anesthetic product included in this delivery order, represents the type of specialized pharmaceutical the contractor supplies to support diverse military medical requirements across global Department of Defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 10/24/25 |